251 related articles for article (PubMed ID: 18957678)
1. Refinement and psychometric evaluation of the impact of cancer scale.
Crespi CM; Ganz PA; Petersen L; Castillo A; Caan B
J Natl Cancer Inst; 2008 Nov; 100(21):1530-41. PubMed ID: 18957678
[TBL] [Abstract][Full Text] [Related]
2. Validation of the French translation-adaptation of the impact of cancer questionnaire version 2 (IOCv2) in a breast cancer survivor population.
Blanchin M; Dauchy S; Cano A; Brédart A; Aaronson NK; Hardouin JB
Health Qual Life Outcomes; 2015 Jul; 13():110. PubMed ID: 26220672
[TBL] [Abstract][Full Text] [Related]
3. Assessing the impact of cancer among Dutch non-Hodgkin lymphoma survivors compared with their American counterparts: a cross-national study.
Oerlemans S; Smith SK; Crespi CM; Zimmerman S; van de Poll-Franse LV; Ganz PA
Psychooncology; 2013 Jun; 22(6):1258-65. PubMed ID: 22833503
[TBL] [Abstract][Full Text] [Related]
4. Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors.
Crespi CM; Smith SK; Petersen L; Zimmerman S; Ganz PA
J Cancer Surviv; 2010 Mar; 4(1):45-58. PubMed ID: 19967410
[TBL] [Abstract][Full Text] [Related]
5. A procedure for obtaining impact of cancer version 2 scores using version 1 responses.
Crespi CM; Ganz PA; Petersen L; Smith SK
Qual Life Res; 2013 Feb; 22(1):103-9. PubMed ID: 22302619
[TBL] [Abstract][Full Text] [Related]
6. Psychometric evaluation of the Brief Cancer Impact Assessment among breast cancer survivors.
Alfano CM; McGregor BA; Kuniyuki A; Reeve BB; Bowen DJ; Wilder Smith A; Baumgartner KB; Bernstein L; Ballard-Barbash R; Malone KE; Ganz PA; McTiernan A
Oncology; 2006; 70(3):190-202. PubMed ID: 16809938
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Cancer Scale (IOC) in Italian long-term cancer survivors: adaptation and psychometric evaluation.
Muzzatti B; Flaiban C; Romito F; Cormio C; Annunziata MA
Support Care Cancer; 2013 Dec; 21(12):3355-62. PubMed ID: 23912670
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the impact of cancer between British and US long-term non-Hodgkin lymphoma survivors.
Sarker SJ; Smith SK; Chowdhury K; Ganz PA; Zimmerman S; Gribben J; Korszun A
Support Care Cancer; 2017 Mar; 25(3):739-748. PubMed ID: 27826873
[TBL] [Abstract][Full Text] [Related]
9. Psychometric evaluation of the Impact of Cancer (IOC-CS) scale for young adult survivors of childhood cancer.
Zebrack BJ; Donohue JE; Gurney JG; Chesler MA; Bhatia S; Landier W
Qual Life Res; 2010 Mar; 19(2):207-18. PubMed ID: 20058086
[TBL] [Abstract][Full Text] [Related]
10. Assessing the impact of cancer: development of a new instrument for long-term survivors.
Zebrack BJ; Ganz PA; Bernaards CA; Petersen L; Abraham L
Psychooncology; 2006 May; 15(5):407-21. PubMed ID: 16097041
[TBL] [Abstract][Full Text] [Related]
11. The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability, and scaling assumptions.
Reulen RC; Zeegers MP; Jenkinson C; Lancashire ER; Winter DL; Jenney ME; Hawkins MM
Health Qual Life Outcomes; 2006 Oct; 4():77. PubMed ID: 17022814
[TBL] [Abstract][Full Text] [Related]
12. Psychometric evaluation of the Persian version of the Lymphedema Life Impact Scale (LLIS, version 1) in breast cancer patients.
Haghighat S; Montazeri A; Zayeri F; Ebrahimi M; Weiss J
Health Qual Life Outcomes; 2018 Jun; 16(1):132. PubMed ID: 29954381
[TBL] [Abstract][Full Text] [Related]
13. Cross-cultural adaptation, reliability and validity of the Spanish version of the Quality of Life in Adult Cancer Survivors (QLACS) questionnaire: application in a sample of short-term survivors.
Escobar A; Trujillo-Martín Mdel M; Rueda A; Pérez-Ruiz E; Avis NE; Bilbao A
Health Qual Life Outcomes; 2015 Nov; 13():182. PubMed ID: 26573805
[TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors.
Alfano CM; McGregor BA; Kuniyuki A; Reeve BB; Bowen DJ; Baumgartner KB; Bernstein L; Ballard-Barbash R; Malone KE; Ganz PA; McTiernan A
Psychooncology; 2006 Nov; 15(11):985-1000. PubMed ID: 16470891
[TBL] [Abstract][Full Text] [Related]
15. Measurement of the quality of life in cancer survivors.
Ferrell BR; Dow KH; Grant M
Qual Life Res; 1995 Dec; 4(6):523-31. PubMed ID: 8556012
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of quality of life instruments in long-term breast cancer survivors.
Chopra I; Kamal KM
Health Qual Life Outcomes; 2012 Jan; 10():14. PubMed ID: 22289425
[TBL] [Abstract][Full Text] [Related]
17. Expanding Application of the Long-Term Quality of Life Instrument to the Population of Women Undergoing Treatment of Advanced Breast Cancer.
Kamp K; Flanigan M; Thana K; Terpstra J; Wyatt G; Sikorskii A
Cancer Nurs; 2021 Mar-Apr 01; 44(2):E76-E82. PubMed ID: 31833917
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for long-term cancer survivors in a sample of breast cancer survivors.
Avis NE; Ip E; Foley KL
Health Qual Life Outcomes; 2006 Dec; 4():92. PubMed ID: 17140438
[TBL] [Abstract][Full Text] [Related]
19. Development of an "Impact of HIV" Instrument for HIV Survivors.
Buscher AL; Kallen MA; Suarez-Almazor ME; Giordano TP
J Assoc Nurses AIDS Care; 2015; 26(6):720-31. PubMed ID: 26324524
[TBL] [Abstract][Full Text] [Related]
20. Psychometric Evaluation of a Korean Version of the Cancer Survivors' Self-efficacy Scale.
Kim SH; Lee BG; Lee JY; Kim SJ; Hur MH; Lee MH; Han MS
Cancer Nurs; 2019; 42(6):509-514. PubMed ID: 30601268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
